Priority Date: 10.08.12 (US 201261682155P)

METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION

  • Application ID: EP13828540
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G01 (MEASURING; TESTING) Kilburn & Strode LLP is specialized in the combination C12 and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Weidner Stern Jeschke, Zacco Denmark A/S, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB and 86 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 10.08.2012 - Priority Date (US 201261682155P)
  • 13.02.2014 - Publication A2 (WO2014026157)
  • 17.06.2015 - Publication A2 (EP2882862)

IPC Classification